Competing Interests

EK, DB, and MW report no conflicts of interest. ND is currently supported by the Canadian Asthma Allery and Immunology Foundation Type II Inflammation Sanofi Genzyme Award. TA and SS are employees of Merck Canada, Inc. KQ reports personal fees from Merck. PH reports grants from Boehringer Ingelheim, Cyclomedica, Grifols, and Vertex, and speaker and/or consulting fees from Acceleron, AstraZeneca, Boehringer Ingelheim, GSK, Grifols, Janssen, Sanofi Genzyme, Takeda, and Valeo. MC reports payment or honoraria speaking from GSK, AstraZeneca, Respiplus, Valeo and Covis. Has received support for attending meetings by Sanofi. Participated in advisory boards for Novartis, GSK, AstraZeneca, Sanofi, Boehringer-Ingelheim, Respiplus, Trudell, Valeo, CMD and Covis. PL reports personal fees from AstraZeneca, Boehringer Ingelheim, and GSK. AE has participated in advisory boards for ALK Abello, AstraZeneca, Aralez, Bausch Health, LEO Pharma, Merck, Novartis, and Pfizer, has been a speaker for ALK Abello, AstraZeneca, Miravo, Medexus, and Mylan. Her institution has received research grants from ALK Abello, Aralez, AstraZeneca, Bayer LLC, Medexus, Novartis, and Regeneron. She has also served as an independent consultant to Bayer LLC and Regeneron. LPB has previously received research grants from Amgen, AstraZeneca, GSK, Merck, Novartis, and Sanofi-Regeneron and speaker and/or consulting fees from AstraZeneca, Covis, Novartis, GSK, Merck, and Sanofi-Regeneron. AK is a member of advisory boards/speaker’s bureaus for AstraZeneca, Behring, Belus, Boehringer Ingelheim, Covis, Cipla, Eisai, GSK, Merck Frosst, Novo Nordisk, Pfizer, Novartis, Sanofi, Teva, Trudell, and Valeo. SKF served on an advisory board for Merck and sponsored talks for GSK and Boehringer-Ingelheim. IS is currently supported by the E.J. Moran Campbell Early Career Award, McMaster University and reports grants from ERS Respire 3 Marie Curie fellowship, Merck, GSK and MITACS and speaker and/or consulting fees from Merck, GSK, AstraZeneca, Roche, Genentech and Respiplus.

Ethical Approval

This survey did not collect patient or clinical data and therefore did not require ethics board review.

Consent to Participate

Informed consent was obtained from all participants in the study.